Hausegger K A, Kugler C, Uggowitzer M, Lammer J, Karaic R, Klein G E, Maurer M
Department of Radiology, Karl-Franzens University, Graz, Austria.
Radiology. 1996 Aug;200(2):437-41. doi: 10.1148/radiology.200.2.8685339.
To evaluate the effectiveness of the self-expanding Wallstent in the treatment of benign biliary strictures.
Twenty patients with benign biliary strictures were included in this retrospective study. Seven patients had chronic pancreatitis, two had fibrous papillary stenosis, one had primary sclerosing cholangitis, and 10 had postsurgical strictures, including four who had a stenosed bilidigestive anastomosis. Primary and secondary patency of the stents and clinical outcome after stent insertion were evaluated.
Stent placement was successful in all patients. At the end of the observation period, which lasted 3-78 months (mean, 31.2 months +/- 4.5 [standard error]), 10 patients were alive. Median primary patency was 32 months +/- 8.7. In 10 patients, patency was preserved during the observation period (two with secondary patency). Six patients had a good clinical result. Among the other four patients, one had recurrent cholangitis, one had a biliary abscess, and two had stent revisions. In the other patients, stents became occluded after 3-55 months. The reason for stent occlusion was a stone in one patient; in the others, the causes were not proved.
Results of stent placement for treatment of benign biliary strictures are not encouraging. However, the patient population is too limited to allow final conclusions.
评估自膨式Wallstent支架治疗良性胆管狭窄的有效性。
本回顾性研究纳入了20例良性胆管狭窄患者。其中7例患有慢性胰腺炎,2例患有纤维性乳头狭窄,1例患有原发性硬化性胆管炎,10例患有术后狭窄,包括4例胆管消化吻合口狭窄患者。评估了支架的原发性和继发性通畅情况以及支架置入后的临床结局。
所有患者支架置入均成功。在为期3至78个月(平均31.2个月±4.5[标准误])的观察期末,10例患者存活。原发性通畅的中位数为32个月±8.7。10例患者在观察期内保持通畅(2例为继发性通畅)。6例患者临床结果良好。在其他4例患者中,1例发生复发性胆管炎,1例发生胆脓肿,2例进行了支架翻修。在其他患者中,支架在3至55个月后闭塞。1例患者支架闭塞原因是结石;其他患者的病因未得到证实。
支架置入治疗良性胆管狭窄的结果并不令人鼓舞。然而,患者群体有限,无法得出最终结论。